COVID-19 Severe Pneumonia
2 clinical trials · Condition
◉ Watch COVID-19 Severe Pneumonia
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia (NCT04369469) | Alexion Pharmaceuticals, Inc. | 2020-05-10 |
| Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen (NCT04435223) | Centre Hospitalier Universitaire Dijon | 2020-04-07 |
Track COVID-19 Severe Pneumonia automatically
Every clearance here is in the API, with alerts when new ones post.